The Delhi High Court on Wednesday asked the Delhi Government to inform it about the stocks of the medicine used for the treatment of Black Fungus.
A division bench of Justice Vipin Sanghi and Justice Jasmeet Singh asked the Delhi Government to give its response tomorrow on the stocks of the Amphotericin B drug and how they planned to distribute it.
The court's queries came after it was informed by petitioner and advocate Rakesh Malhotra that there is a shortage in the supply of medicines used to treat Black Fungus - a new issue in the ongoing Covid-19 pandemic.
The court also asked how there can suddenly be a shortage in supply when the drug is being manufactured locally and remarked that this cannot be a case of artificial shortage.
The Court has listed the matter for further hearing tomorrow.
Senior Advocate Rahul Mehra, appearing for the Delhi Government said that this issue is part of amicus note. It has been requisitioned from the Centre and there is a committee which meets twice a day, submitted to Rahul Mehra and said that he will come back tomorrow.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)